SKI Market

A+| A| A-|

Indian Indices

Sensex

75,035.26 -165.59
( -0.22%)

Global Indices

Nasdaq

49,407.34 -299.79
(-0.60%)

Dow Jones

7,377.26 -46.79
(-0.63%)

Hang Seng

59,717.33 -833.26
(-1.38%)

Nikkei 225

10,329.19 5.44
(0.05%)

Forex

USD-INR

96.22 0.33
(0.34%)

EUR-INR

111.98 0.52
(0.46%)

GBP-INR

128.69 0.96
(0.75%)

JPY-INR

0.61 0.00
(0.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Lypsa Gems & Jewellery Ltd

Industry : Diamond Cutting / Jewellery

BSE Code

ISIN Demat

Book Value()

534532

INE142K01011

5.6345815

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LYPSAGEMS

14.77

EPS(TTM)

Face Value()

Div & Yield %

Back

mrf ltd

Balaxi Pharmaceuticals consolidated net profit declines 94.22% in the December 2025 quarter

Feb 02,2026

Net profit of Balaxi Pharmaceuticals declined 94.22% to Rs 0.31 crore in the quarter ended December 2025 as against Rs 5.36 crore during the previous quarter ended December 2024. Sales declined 1.02% to Rs 72.54 crore in the quarter ended December 2025 as against Rs 73.29 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	72.54	73.29	-1
OPM %	4.26	5.44	-
PBDT	2.17	6.55	-67
PBT	1.61	6.07	-73
NP	0.31	5.36	-94

75,035.26 -165.59 ( -0.22%)

49,407.34 -299.79 (-0.60%)

7,377.26 -46.79 (-0.63%)

59,717.33 -833.26 (-1.38%)

10,329.19 5.44 (0.05%)

96.22 0.33 (0.34%)

111.98 0.52 (0.46%)

128.69 0.96 (0.75%)

0.61 0.00 (0.28%)